The short version
20 companies supply this market — deep enough that no single failure threatens the supply.
Market view
bendamustine hydrochloride
27 marketed package NDCs · 20 active manufacturers
Most dispensed: 1 kg/kg · Powder · #1 kg/drum · 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · #1 vial, single-dose/carton / 20 ml in 1 vial, single-dose · 25 mg/5mL · Injection, Powder, Lyophilized, For Solution · #1 vial, single-dose/carton / 5 ml in 1 vial, single-dose
What changed in the last 90 days
Every detected change for bendamustine hydrochloride, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- TreandaJul 24, 2026New shortageby this manufacturerCephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.)'s Treanda (Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton) is newly in shortage20 companies market treanda
Same drug class
Other molecules FDA puts in Alkylating Drug, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Bendamustine hydrochloride in shortage right now?
- No. FDA does not currently list Bendamustine hydrochloride in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Bendamustine hydrochloride?
- 20 companies have marketed Bendamustine hydrochloride in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
Shortage reports for this molecule
- Planned discontinuation — Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08)Jul 23, 2026
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.